Print Page | Close Window

Help NICE in reviewing Ablative Therapies

Printed From: Barrett's Support Forum
Category: Barrett's Support Forum
Forum Name: Barrett's Oesophagus
Forum Discription: Your Questions about Barrett's Oesophagus
Printed Date: 09 Dec 2019 at 10:31pm

Topic: Help NICE in reviewing Ablative Therapies
Posted By: gblyth
Subject: Help NICE in reviewing Ablative Therapies
Date Posted: 13 Mar 2009 at 10:17pm

NICE recently held a meeting to discuss preparation of a short clinical guideline for ablative therapy for people with Barrett’s Oesophagus. They need input from Patients and Public. This guideline will look at treatments such as Radio Frequency Ablation (The Halo System from Barrx Medical) - -

Become a lay member of the development group looking at ablative therapy for Barrett’s Oesophagus

The - Patient and Public Involvement Programme and theNICE short guidelines team are looking for applications from patients and carers to sit on the group developing a short clinical guideline for ablative therapy for people with Barrett’s Oesophagus. Barrett’s oesophagus is a term used to describe cell changes to the lower part of the oesophagus (gullet), thought to be caused by long-term exposure to stomach acid. It is associated with an increased risk of oesophageal cancer. Ablative therapy is a type of treatment available to people with Barrett’s oesophagus and can include techniques such as argon plasma coagulation (APC), photodynamic therapy (PDT), laser ablation, cryotherapy, multipolar electrocoagulation (MPEC), and radiofrequency ablation (RFA).

These members of this group will play a key role in making sure that patients’ and carers’ views, experiences and interests inform the guideline's development and its recommendations to the NHS.

All members of the guideline development group have equal status, which reflects the relevance and importance of their different expertise and experience. They include health professionals and researchers as well as patient and carer members. All Group members need to attend regular meetings and undertake background reading.

Skills and experience

We would welcome an application from you if you have:

  • experience or knowledge of ablative therapy for Barrett’s oesophagus for example, as someone who:
    • has been treated with ablative therapy for Barrett’s oesophagus themselves or
    • who is the relative or partner of someone with experience or
    • who is a policy officer from a relevant patient organisation
  • an understanding of, and a willingness to reflect, the experiences and needs of a wide network of relevant people (perhaps as a member of a support group or organisation)
  • time to commit to the work of the group: attending meetings, background reading, commenting on draft products etc.
  • good communication and team working skills

Health professionals will be well represented on the group so we are looking for someone without a health professional background.


Members of the guideline development group representing patients’ and carers’ interests are paid an attendance fee and travel expenses are also reimbursed. The Patient and Public Involvement Programme will provide these members with dedicated and ongoing support throughout their time on the Group.

Tax and benefits

Please note that attendance fees and reimbursable expenses are subject to the usual tax and benefit rules that apply to earned income.

How to apply

Please read the role description and person specification, information for applicants and recruitment pack using the links below. If you are interested in applying please complete and return the application form, equalities monitoring form and declaration of interest form.

  • - Patient/carer members role description and person specification
  • - Application form and personal statement
  • - Information for applicants
  • - Recruitment pack (contains all relevant forms, policies and procedures)

If you have any questions or wish to discuss the role further, please contact Laura Norburn, - .

Decisions about who to recruit to the Guideline Development Group will rest with the NICE team. Please note that submitting an application does not automatically guarantee a place on the Group.

The following forms should be completed and returned:

  • Application form and personal statement
  • - Equalities monitoring form
  • - Declaration of Interests form

If you would like to receive hard copies of any forms, please email or write to Laura Norburn. You will need to return the forms (either in hard copy or in electronic format) to:

Laura Norburn
Patient and Public Involvement Programme
MidCity Place
London,WC1V 6NA

Email: -

Please return your completed forms by 9thApril 2009.

Please note that an advertisement for health professional membership of the group can be found - here .

Equality and Diversity

NICE is committed to the values of equality and diversity and welcomes applications from all sections of the community.

More information

  • - Barrett’s Oesophagus guideline project
  • - Patient and Public Involvement Programme

I would like to declare that I am a director of SynMed Limited the company that distributes the Halo Treatment from Barrx Medical in the UK.

Geoffrey Blyth

Print Page | Close Window